BACKGROUND AND PURPOSE: Reliable markers to monitor PPMS are still needed. We investigated whether conventional and DTI measures of thalamic damage are predictive of long-term disability accumulation in PPMS. MATERIALS AND METHODS: Brain conventional and DTI scans were obtained at baseline and after a mean follow-up of 15 months in 54 patients with PPMS and 8 healthy controls. Patients were reassessed clinically after 5 years. At baseline and follow-up, measures of lesion load, brain atrophy, and NTV were obtained. MD and FA histograms of the NAWM, the whole GM without the thalami, and the thalami were obtained. A multivariate analysis evaluated the predictors of long-term neurologic deterioration. RESULTS: At follow-up, 35 patients showed disability worsening. At baseline, compared with healthy controls, patients with PPMS had lower NTV (P < .001) and thalamic FA (P = .002) and higher thalamic (P = .002) and whole GM without the thalami (P = .005) MD. During follow-up, the change of thalamic FA was higher in PPMS versus healthy controls (P = .01). Baseline NTV and thalamic DTI quantities differed significantly between patients with PPMS with and without thalamic lesions. Baseline thalamic quantities were significantly correlated with the extent of brain T2 lesions and the severity of NAWM damage. The multivariate model included average NAWM MD (OR = 1.46, P = .005) and FA thalamic change (OR = 0.84, P = .02) as independent predictors of EDSS score deterioration (Nagelkerke R(2) = 0.55). CONCLUSIONS: Short-term accrual of thalamic damage and the severity of NAWM involvement predict the long-term accumulation of disability in PPMS.
BACKGROUND AND PURPOSE: Reliable markers to monitor PPMS are still needed. We investigated whether conventional and DTI measures of thalamic damage are predictive of long-term disability accumulation in PPMS. MATERIALS AND METHODS: Brain conventional and DTI scans were obtained at baseline and after a mean follow-up of 15 months in 54 patients with PPMS and 8 healthy controls. Patients were reassessed clinically after 5 years. At baseline and follow-up, measures of lesion load, brain atrophy, and NTV were obtained. MD and FA histograms of the NAWM, the whole GM without the thalami, and the thalami were obtained. A multivariate analysis evaluated the predictors of long-term neurologic deterioration. RESULTS: At follow-up, 35 patients showed disability worsening. At baseline, compared with healthy controls, patients with PPMS had lower NTV (P < .001) and thalamic FA (P = .002) and higher thalamic (P = .002) and whole GM without the thalami (P = .005) MD. During follow-up, the change of thalamic FA was higher in PPMS versus healthy controls (P = .01). Baseline NTV and thalamic DTI quantities differed significantly between patients with PPMS with and without thalamic lesions. Baseline thalamic quantities were significantly correlated with the extent of brain T2 lesions and the severity of NAWM damage. The multivariate model included average NAWM MD (OR = 1.46, P = .005) and FA thalamic change (OR = 0.84, P = .02) as independent predictors of EDSS score deterioration (Nagelkerke R(2) = 0.55). CONCLUSIONS: Short-term accrual of thalamic damage and the severity of NAWM involvement predict the long-term accumulation of disability in PPMS.
Authors: Stephen M Smith; Yongyue Zhang; Mark Jenkinson; Jacqueline Chen; P M Matthews; Antonio Federico; Nicola De Stefano Journal: Neuroimage Date: 2002-09 Impact factor: 6.556
Authors: M Rovaris; M Bozzali; G Santuccio; A Ghezzi; D Caputo; E Montanari; A Bertolotto; R Bergamaschi; R Capra; G Mancardi; V Martinelli; G Comi; M Filippi Journal: Brain Date: 2001-12 Impact factor: 13.501
Authors: Alexandra Kutzelnigg; Claudia F Lucchinetti; Christine Stadelmann; Wolfgang Brück; Helmut Rauschka; Markus Bergmann; Manfred Schmidbauer; Joseph E Parisi; Hans Lassmann Journal: Brain Date: 2005-10-17 Impact factor: 13.501
Authors: M Calabrese; M A Rocca; M Atzori; I Mattisi; V Bernardi; A Favaretto; L Barachino; C Romualdi; L Rinaldi; P Perini; P Gallo; M Filippi Journal: Neurology Date: 2009-04-14 Impact factor: 9.910
Authors: Jaume Sastre-Garriga; Gordon T Ingle; Declan T Chard; Mara Cercignani; Lluís Ramió-Torrentà; David H Miller; Alan J Thompson Journal: Brain Date: 2005-04-07 Impact factor: 13.501
Authors: Francesco Manfredonia; Olga Ciccarelli; Zhaleh Khaleeli; Daniel J Tozer; Jaume Sastre-Garriga; David H Miller; Alan J Thompson Journal: Arch Neurol Date: 2007-03
Authors: Alvino Bisecco; Maria A Rocca; Elisabetta Pagani; Laura Mancini; Christian Enzinger; Antonio Gallo; Hugo Vrenken; Maria Laura Stromillo; Massimiliano Copetti; David L Thomas; Franz Fazekas; Gioacchino Tedeschi; Frederik Barkhof; Nicola De Stefano; Massimo Filippi Journal: Hum Brain Mapp Date: 2015-04-14 Impact factor: 5.038
Authors: Peter Matthew Kennedy de Blank; Jeffrey Ira Berman; Grant T Liu; Timothy Paul Leslie Roberts; Michael Jay Fisher Journal: Neuro Oncol Date: 2013-05-07 Impact factor: 12.300
Authors: Alireza Minagar; Michael H Barnett; Ralph H B Benedict; Daniel Pelletier; Istvan Pirko; Mohamad Ali Sahraian; Elliott Frohman; Robert Zivadinov Journal: Neurology Date: 2013-01-08 Impact factor: 9.910
Authors: Isabela T Borges; Colin D Shea; Joan Ohayon; Blake C Jones; Roger D Stone; John Ostuni; Navid Shiee; Henry McFarland; Bibiana Bielekova; Daniel S Reich Journal: Mult Scler Relat Disord Date: 2013-04-01 Impact factor: 4.339
Authors: Renuka Natarajan; Sanna Hagman; Xingchen Wu; Ullamari Hakulinen; Minna Raunio; Mika Helminen; Maija Rossi; Prasun Dastidar; Irina Elovaara Journal: Mult Scler Int Date: 2013-12-17